Marciana Nona Duma
Papers
2
Total Citations
206
H-Index
2
About
Marciana Nona Duma is a leading figure in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for treating oligometastatic disease and early-stage cancers. Her major contributions lie in establishing large-scale, real-world evidence through collaborative database initiatives, most notably as a driving force behind the German Society for Radiation Oncology (DEGRO) SBRT database. Her landmark 2018 study, cited over 150 times, analyzed patterns of care and outcomes for 474 patients with 623 liver oligometastases, providing critical insights into factors influencing local control and overall survival. This work has helped standardize SBRT practice and define its role in managing metastatic disease. Additionally, her 2017 planning benchmark study for SBRT in early-stage non-small cell lung cancer (NSCLC), with over 50 citations, has improved treatment planning consistency across institutions. Through these efforts, Duma has significantly advanced the evidence base for SBRT, bridging the gap between clinical trials and routine practice. Her work continues to shape how radiation oncologists approach both primary lung tumors and metastatic liver lesions, making her a key contributor to the field’s evolution toward more precise, non-invasive cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2Planning benchmark study for SBRT of early stage NSCLC54 citations · 2017